'Buffalo hump' associated with the use of indinavir;'Bosse de bison' associee a la prise d'indinavir

Annales de Dermatologie et de Venereologie

Volumn 126, Issue 10, 1999, Pages 720-722

  Dornier, C ^a   Posth, M ^a   Granel, F ^a   Barbaud, A ^a   Schmutz, J L ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; ZALCITABINE; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; LIPODYSTROPHY; MALE; METABOLIC DISORDER; ADIPOSE TISSUE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LIPOMATOSIS; NECK;

ADIPOSE TISSUE; ADULT; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; LIPODYSTROPHY; LIPOMATOSIS; MALE; NECK;

EID: 0033202068     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ruane PJ. Atypical accumulation of fatty Tissue. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, September 1997 (Abstract I 185).
2. Massip P, Marchou B, Bonnet E, Cuzin L, Montastruc JL. Lipodystrophia with protease inhibitors in HIV patients. Therapie 1997;52:615.
3. Hengel RL, Watts MB, Lennox JL. Benign symmetric lipomatosis associated with protease inhibitors. Lancet 1997;350:1596.
4. Herry I, Bernard L, DeTruchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997;25:937-8.
5. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. « Buffalo hump » in men with HIV-1 infection. Lancet 1998;351:867-70.
6. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5.
7. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-F58.
8. Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328.
9. Henry K, Melroe H, Huebsch J, Hermundson J, Simpson J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 1998;352:1031-2.
10. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998;351:1881-3.
11. Gagnon AM, Angel JB, Sorisky A. Protease inhibitors and adipocyte differentiation in cell culture. Lancet 1998;352:1032.
12. Saint-Marc T, Touraine JL « Buffalo hump » in HIV-1 infection. Lancet 1998;352:319-20.